Showing results (1391-1400 of 1,768) with videos related to

Sort By:
Pageof 177
JAMA Neurology|June 20, 2017
Brain Calcifications in Adult-Onset Genetic Leukoencephalopathies: A ReviewXavier Ayrignac, Gaël Nicolas, Clarisse Carra-Dallière, et al.
JAMA Neurology|May 31, 2017
Complex and Dynamic Chromosomal Rearrangements in a Family With Seemingly Non-Mendelian Inheritance of Dopa-Responsive DystoniaKatja Lohmann, Claire Redin, Holger Tönnies, et al.
JAMA Neurology|June 13, 2017
ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical TrialRajesh Pahwa, Caroline M Tanner, Robert A Hauser, et al.
JAMA Neurology|October 25, 2021
Left Ventricular Dysfunction Among Patients With Embolic Stroke of Undetermined Source and the Effect of Rivaroxaban vs Aspirin: A Subgroup Analysis of the NAVIGATE ESUS Randomized Clinical TrialAlexander E Merkler, Lesly A Pearce, Scott E Kasner, et al.
JAMA Neurology|February 7, 2022
Comparison of Mobile Stroke Unit With Usual Care for Acute Ischemic Stroke Management: A Systematic Review and Meta-analysisGuillaume Turc, Melika Hadziahmetovic, Silke Walter, et al.
JAMA Neurology|April 11, 2022
Prediction of Long-term Survival After Status Epilepticus Using the ACD ScoreLars Egil Roberg, Olav Monsson, Simon Bang Kristensen, et al.
JAMA Neurology|January 31, 2022
Association of BDNF Val66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer DiseaseYen Ying Lim, Paul Maruff, Nicolas R Barthélemy, et al.
JAMA Neurology|September 23, 2021
Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With OcrelizumabLivnat Brill, Ariel Rechtman, Omri Zveik, et al.
JAMA Neurology|January 24, 2022
Association of Ischemic Stroke Incidence, Severity, and Recurrence With Dementia in the Atherosclerosis Risk in Communities Cohort StudySilvia Koton, James Russell Pike, Michelle Johansen, et al.
JAMA Neurology|July 25, 2022
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple SclerosisEmilio Portaccio, Mattia Fonderico, Pietro Iaffaldano, et al.
Pageof 177